{"id":41885,"date":"2025-04-28T13:22:53","date_gmt":"2025-04-28T12:22:53","guid":{"rendered":"https:\/\/nightwatchepilepsy.com\/press-release\/"},"modified":"2025-10-01T14:18:38","modified_gmt":"2025-10-01T13:18:38","slug":"press-release","status":"publish","type":"page","link":"https:\/\/nightwatchepilepsy.com\/it\/press-release\/","title":{"rendered":"Press release"},"content":{"rendered":"

[et_pb_section fb_built=”1″ module_id=”Eventkalender” _builder_version=”4.27.4″ _module_preset=”default” background_color=”#FFFFFF” locked=”off” global_colors_info=”{}”][et_pb_row _builder_version=”4.27.4″ _module_preset=”default” custom_padding=”||0px||false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text module_id=”Agenda1″ _builder_version=”4.27.4″ _module_preset=”default” locked=”off” global_colors_info=”{}”]<\/p>\n

\n

LivAssured joins Abilia, strengthening international reach for NightWatch Seizure Monitoring for epilepsy.<\/h1>\n<\/div>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.27.4″ _module_preset=”default” custom_margin=”||||false|false” custom_padding=”||||false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https:\/\/nightwatchepilepsy.com\/wp-content\/uploads\/2025\/10\/NightWatch_Abilia.jpeg” title_text=”NightWatch_Abilia” align=”center” _builder_version=”4.27.4″ _module_preset=”default” width=”80%” width_tablet=”90%” width_phone=”100%” width_last_edited=”on|phone” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.27.4″ _module_preset=”default” custom_padding=”0px||||false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text module_id=”Agenda1″ _builder_version=”4.27.4″ _module_preset=”default” locked=”off” global_colors_info=”{}”]<\/p>\n

Leiden, The Netherlands \u2013 September 29, 2025 \u2013 LivAssured B.V. announces that it will become part of Abilia, a subsidiary of MedCap AB (publ) and a leading provider of assistive technology solutions in Scandinavia and Europe.<\/span><\/i><\/p>\n

LivAssured was founded from a Dutch research consortium with the mission to develop NightWatch, a clinically validated seizure monitor designed to detect severe epileptic seizures during sleep. Since its market introduction in 2018, NightWatch has had a significant positive impact across the epilepsy community in Europe, supporting patients, caregivers, and healthcare professionals with reliable detection and real-time alerts. Today, the system is used by thousands of families and care institutions and has proven its value in both daily life and clinical practice.<\/span><\/i><\/p>\n

Abilia, headquartered in Sweden, has decades of experience developing and providing assistive technology in areas such as cognition, communication, environmental control, and alarms. Abilia\u2019s solutions are built on evidence and close collaboration with healthcare professionals, with the goal of empowering people with special needs to live more independent lives.<\/span><\/i><\/p>\n

The acquisition of LivAssured significantly strengthens Abilia’s existing offering in seizure monitoring and creates new opportunities for international expansion. With Abilia’s established market presence and expertise, LivAssured will be able to accelerate its growth and ensure more people with epilepsy and their caregivers benefit from reliable seizure detection.<\/span><\/i><\/p>\n

\u201cWe are proud of what we have achieved with NightWatch together with our partners and the epilepsy community over the past years,\u201d said Jeroen van den Hout, CEO of LivAssured. \u201cBy joining Abilia, we can take the next step in our mission and bring NightWatch to even more families worldwide.\u201d<\/span><\/i><\/p>\n

Tove Christiansson, Head of Business Area Assistive Tech and CEO of Abilia, added: \u201cAbilia\u2019s mission has always been to empower people through innovative, reliable, and user-centric assistive technology. With this acquisition, we\u2019re deepening that mission and reinforcing our dedication to delivering solutions that truly matter. We are excited to welcome the LivAssured team to Abilia.\u201d<\/span><\/i><\/p>\n

About LivAssured<\/i><\/b>
<\/i><\/b>LivAssured B.V., based in Leiden, the Netherlands, develops NightWatch, a clinically validated seizure detection system worn on the upper arm during sleep. NightWatch originates from a Dutch research consortium, including Kempenhaeghe, UMCU, SEIN, and EpilepsieNL. It detects major motor seizures during sleep, providing timely alerts to caregivers and supporting better epilepsy management.<\/span><\/i><\/p>\n

About Abilia<\/i><\/b>
<\/i><\/b>Abilia, headquartered in Sweden, provides assistive technology for people with special needs in cognition, communication, environmental control, and alarms. With over 50 years of experience, Abilia empowers individuals to live independent lives and supports healthcare professionals and caregivers with evidence-based solutions. Abilia is part of the publicly listed MedCap AB (publ).<\/span><\/i><\/p>\n

[\/et_pb_text][et_pb_button button_url=”@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9wYWdlIiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjE2In19@” button_text=”Go to NightWatch+” button_alignment=”center” _builder_version=”4.27.4″ _dynamic_attributes=”button_url” _module_preset=”default” global_colors_info=”{}”][\/et_pb_button][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"

LivAssured joins Abilia, strengthening international reach for NightWatch Seizure Monitoring for epilepsy. Leiden, The Netherlands \u2013 September 29, 2025 \u2013 LivAssured B.V. announces that it will become part of Abilia, a subsidiary of MedCap AB (publ) and a leading provider of assistive technology solutions in Scandinavia and Europe. LivAssured was founded from a Dutch research […]<\/p>\n","protected":false},"author":3,"featured_media":39668,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"class_list":["post-41885","page","type-page","status-publish","has-post-thumbnail","hentry"],"yoast_head":"\nNightWatch+ press release<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nightwatchepilepsy.com\/it\/press-release\/\" \/>\n<meta property=\"og:locale\" content=\"it_IT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NightWatch+ press release\" \/>\n<meta property=\"og:description\" content=\"LivAssured joins Abilia, strengthening international reach for NightWatch Seizure Monitoring for epilepsy. Leiden, The Netherlands \u2013 September 29, 2025 \u2013 LivAssured B.V. announces that it will become part of Abilia, a subsidiary of MedCap AB (publ) and a leading provider of assistive technology solutions in Scandinavia and Europe. LivAssured was founded from a Dutch research […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nightwatchepilepsy.com\/it\/press-release\/\" \/>\n<meta property=\"og:site_name\" content=\"NightWatch\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/EpilepsySeizureDetectionEN\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-01T13:18:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nightwatchepilepsy.com\/wp-content\/uploads\/2024\/10\/NightWatch_arm-modulebase-station_medium-shadow.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"720\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"NightWatch news | Current and relevant subjects\" \/>\n<meta name=\"twitter:description\" content=\"Information about NightWatch, epilepsy and other relevant subjects.\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/nightwatchepilepsy.com\/wp-content\/uploads\/2022\/02\/NightWatch_basisstationarmmodule.png\" \/>\n<meta name=\"twitter:site\" content=\"@NightWatchAlarm\" \/>\n<meta name=\"twitter:label1\" content=\"Tempo di lettura stimato\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minuti\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nightwatchepilepsy.com\\\/it\\\/press-release\\\/\",\"url\":\"https:\\\/\\\/nightwatchepilepsy.com\\\/it\\\/press-release\\\/\",\"name\":\"NightWatch+ press release\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nightwatchepilepsy.com\\\/it\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nightwatchepilepsy.com\\\/it\\\/press-release\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nightwatchepilepsy.com\\\/it\\\/press-release\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nightwatchepilepsy.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/NW_arm-module-2_medium-shadow-1.png\",\"datePublished\":\"2025-04-28T12:22:53+00:00\",\"dateModified\":\"2025-10-01T13:18:38+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nightwatchepilepsy.com\\\/it\\\/press-release\\\/#breadcrumb\"},\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nightwatchepilepsy.com\\\/it\\\/press-release\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/nightwatchepilepsy.com\\\/it\\\/press-release\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nightwatchepilepsy.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/NW_arm-module-2_medium-shadow-1.png\",\"contentUrl\":\"https:\\\/\\\/nightwatchepilepsy.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/NW_arm-module-2_medium-shadow-1.png\",\"width\":720,\"height\":720},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nightwatchepilepsy.com\\\/it\\\/press-release\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nightwatchepilepsy.com\\\/it\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Press release\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nightwatchepilepsy.com\\\/it\\\/#website\",\"url\":\"https:\\\/\\\/nightwatchepilepsy.com\\\/it\\\/\",\"name\":\"NightWatch\",\"description\":\"Epilepsy seizure detection | Warns during sleep\",\"publisher\":{\"@id\":\"https:\\\/\\\/nightwatchepilepsy.com\\\/it\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nightwatchepilepsy.com\\\/it\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"it-IT\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nightwatchepilepsy.com\\\/it\\\/#organization\",\"name\":\"NightWatch Epilepsy Seizure Detection\",\"alternateName\":\"NightWatch\",\"url\":\"https:\\\/\\\/nightwatchepilepsy.com\\\/it\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/nightwatchepilepsy.com\\\/it\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nightwatchepilepsy.com\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/NightWatch-Logo.png\",\"contentUrl\":\"https:\\\/\\\/nightwatchepilepsy.com\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/NightWatch-Logo.png\",\"width\":696,\"height\":696,\"caption\":\"NightWatch Epilepsy Seizure Detection\"},\"image\":{\"@id\":\"https:\\\/\\\/nightwatchepilepsy.com\\\/it\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/EpilepsySeizureDetectionEN\",\"https:\\\/\\\/x.com\\\/NightWatchAlarm\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/nightwatch-epilepsy-detection\\\/\",\"https:\\\/\\\/www.instagram.com\\\/nightwatch_epilepsie_detectie\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NightWatch+ press release","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nightwatchepilepsy.com\/it\/press-release\/","og_locale":"it_IT","og_type":"article","og_title":"NightWatch+ press release","og_description":"LivAssured joins Abilia, strengthening international reach for NightWatch Seizure Monitoring for epilepsy. Leiden, The Netherlands \u2013 September 29, 2025 \u2013 LivAssured B.V. announces that it will become part of Abilia, a subsidiary of MedCap AB (publ) and a leading provider of assistive technology solutions in Scandinavia and Europe. LivAssured was founded from a Dutch research […]","og_url":"https:\/\/nightwatchepilepsy.com\/it\/press-release\/","og_site_name":"NightWatch","article_publisher":"https:\/\/www.facebook.com\/EpilepsySeizureDetectionEN","article_modified_time":"2025-10-01T13:18:38+00:00","og_image":[{"width":1280,"height":720,"url":"https:\/\/nightwatchepilepsy.com\/wp-content\/uploads\/2024\/10\/NightWatch_arm-modulebase-station_medium-shadow.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_title":"NightWatch news | Current and relevant subjects","twitter_description":"Information about NightWatch, epilepsy and other relevant subjects.","twitter_image":"https:\/\/nightwatchepilepsy.com\/wp-content\/uploads\/2022\/02\/NightWatch_basisstationarmmodule.png","twitter_site":"@NightWatchAlarm","twitter_misc":{"Tempo di lettura stimato":"3 minuti"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/nightwatchepilepsy.com\/it\/press-release\/","url":"https:\/\/nightwatchepilepsy.com\/it\/press-release\/","name":"NightWatch+ press release","isPartOf":{"@id":"https:\/\/nightwatchepilepsy.com\/it\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nightwatchepilepsy.com\/it\/press-release\/#primaryimage"},"image":{"@id":"https:\/\/nightwatchepilepsy.com\/it\/press-release\/#primaryimage"},"thumbnailUrl":"https:\/\/nightwatchepilepsy.com\/wp-content\/uploads\/2024\/11\/NW_arm-module-2_medium-shadow-1.png","datePublished":"2025-04-28T12:22:53+00:00","dateModified":"2025-10-01T13:18:38+00:00","breadcrumb":{"@id":"https:\/\/nightwatchepilepsy.com\/it\/press-release\/#breadcrumb"},"inLanguage":"it-IT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nightwatchepilepsy.com\/it\/press-release\/"]}]},{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/nightwatchepilepsy.com\/it\/press-release\/#primaryimage","url":"https:\/\/nightwatchepilepsy.com\/wp-content\/uploads\/2024\/11\/NW_arm-module-2_medium-shadow-1.png","contentUrl":"https:\/\/nightwatchepilepsy.com\/wp-content\/uploads\/2024\/11\/NW_arm-module-2_medium-shadow-1.png","width":720,"height":720},{"@type":"BreadcrumbList","@id":"https:\/\/nightwatchepilepsy.com\/it\/press-release\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nightwatchepilepsy.com\/it\/"},{"@type":"ListItem","position":2,"name":"Press release"}]},{"@type":"WebSite","@id":"https:\/\/nightwatchepilepsy.com\/it\/#website","url":"https:\/\/nightwatchepilepsy.com\/it\/","name":"NightWatch","description":"Epilepsy seizure detection | Warns during sleep","publisher":{"@id":"https:\/\/nightwatchepilepsy.com\/it\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nightwatchepilepsy.com\/it\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"it-IT"},{"@type":"Organization","@id":"https:\/\/nightwatchepilepsy.com\/it\/#organization","name":"NightWatch Epilepsy Seizure Detection","alternateName":"NightWatch","url":"https:\/\/nightwatchepilepsy.com\/it\/","logo":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/nightwatchepilepsy.com\/it\/#\/schema\/logo\/image\/","url":"https:\/\/nightwatchepilepsy.com\/wp-content\/uploads\/2023\/02\/NightWatch-Logo.png","contentUrl":"https:\/\/nightwatchepilepsy.com\/wp-content\/uploads\/2023\/02\/NightWatch-Logo.png","width":696,"height":696,"caption":"NightWatch Epilepsy Seizure Detection"},"image":{"@id":"https:\/\/nightwatchepilepsy.com\/it\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/EpilepsySeizureDetectionEN","https:\/\/x.com\/NightWatchAlarm","https:\/\/www.linkedin.com\/company\/nightwatch-epilepsy-detection\/","https:\/\/www.instagram.com\/nightwatch_epilepsie_detectie\/"]}]}},"_links":{"self":[{"href":"https:\/\/nightwatchepilepsy.com\/it\/wp-json\/wp\/v2\/pages\/41885","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nightwatchepilepsy.com\/it\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/nightwatchepilepsy.com\/it\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/nightwatchepilepsy.com\/it\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/nightwatchepilepsy.com\/it\/wp-json\/wp\/v2\/comments?post=41885"}],"version-history":[{"count":5,"href":"https:\/\/nightwatchepilepsy.com\/it\/wp-json\/wp\/v2\/pages\/41885\/revisions"}],"predecessor-version":[{"id":43266,"href":"https:\/\/nightwatchepilepsy.com\/it\/wp-json\/wp\/v2\/pages\/41885\/revisions\/43266"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nightwatchepilepsy.com\/it\/wp-json\/wp\/v2\/media\/39668"}],"wp:attachment":[{"href":"https:\/\/nightwatchepilepsy.com\/it\/wp-json\/wp\/v2\/media?parent=41885"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}